Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in <i>Pseudomonas aeruginosa</i>

Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in <i>Pseudomonas aeruginosa</i>

The ability to rescue the activity of antimicrobials that are no longer effective against bacterial pathogens such as <i>Pseudomonas aeruginosa</i> is an attractive strategy to combat antimicrobial drug resistance. Herein, novel efflux pump inhibitors (EPIs) demonstrating strong potentia...

Full description

Bibliographic Details
Main Authors:	Yi Yuan, Jesus D. Rosado-Lugo, Yongzheng Zhang, Pratik Datta, Yangsheng Sun, Yanlu Cao, Anamika Banerjee, Ajit K. Parhi
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Antibiotics
Subjects:	<i>Pseudomonas aeruginosa</i> RND efflux pumps efflux pump inhibitors heterocyclic carboxamides antimicrobial drug resistance
Online Access:	https://www.mdpi.com/2079-6382/11/1/30

Similar Items

Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in <i>Pseudomonas</i> <i>aeruginosa</i>
by: Yongzheng Zhang, et al.
Published: (2022-05-01)

Characterization and Molecular Determinants for β-Lactam Specificity of the Multidrug Efflux Pump AcrD from <i>Salmonella typhimurium</i>
by: Jenifer Cuesta Bernal, et al.
Published: (2021-12-01)

Contribution of RND-Type Efflux Pumps in Reduced Susceptibility to Biocides in <i>Acinetobacter baumannii</i>
by: Christina Meyer, et al.
Published: (2022-11-01)

Molecular Determinants for OMF Selectivity in Tripartite RND Multidrug Efflux Systems
by: Esther Boyer, et al.
Published: (2022-01-01)

RND Efflux Systems Contribute to Resistance and Virulence of <i>Aliarcobacter butzleri</i>
by: Cristiana Mateus, et al.
Published: (2021-07-01)

Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
by: Juerg eDreier, et al.
Published: (2015-07-01)

Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria
by: Anne Davin-Regli, et al.
Published: (2021-09-01)

Role of RND Efflux Pumps in Drug Resistance of Cystic Fibrosis Pathogens
by: Viola Camilla Scoffone, et al.
Published: (2021-07-01)

Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii
by: Bahare Salehi, et al.
Published: (2021-03-01)

Detection of Multidrug-Resistant RND Efflux Pumps and Regulatory Proteins in Antibiotic-Resistant <i>P. aeruginosa</i> Recovered from Hospital Wastewater Effluent in the Eastern Cape Province of South Africa
by: Joan U. Okafor, et al.
Published: (2023-10-01)

Comparative Analysis of Potential Determinants of Resistance to Aminoglycosides in <i>Burkholderia pseudomallei</i> Strains with Different Level of Sensitivity to Gentamicin
by: P. R. Chirskov, et al.
Published: (2022-10-01)

The Art of War with <i>Pseudomonas aeruginosa</i>: Targeting Mex Efflux Pumps Directly to Strategically Enhance Antipseudomonal Drug Efficacy
by: Asiyeh Avakh, et al.
Published: (2023-08-01)

Required criteria of drug efflux pump inhibitors to disrupt the function of AcrB subunit protein from AcrAB-TolC multidrug efflux pump from Escherichia coli
by: Rawaf Alenazy
Published: (2024-04-01)

New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria
by: Gabriella Spengler, et al.
Published: (2017-03-01)

Ever-Adapting RND Efflux Pumps in Gram-Negative Multidrug-Resistant Pathogens: A Race against Time
by: Martijn Zwama, et al.
Published: (2021-06-01)

The RND Efflux Pump Gene Expression in the Biofilm Formation of <i>Acinetobacter baumannii</i>
by: Ola A. Abd El-Rahman, et al.
Published: (2023-02-01)

Types and Mechanisms of Efflux Pump Systems and the Potential of Efflux Pump Inhibitors in the Restoration of Antimicrobial Susceptibility, with a Special Reference to <i>Acinetobacter baumannii</i>
by: Kira M. Zack, et al.
Published: (2024-02-01)

Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria
by: Nina Compagne, et al.
Published: (2023-01-01)

Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from <i>Escherichia coli</i>
by: Rawaf Alenazy
Published: (2022-09-01)

Exploring the Contribution of the AcrB Homolog MdtF to Drug Resistance and Dye Efflux in a Multidrug Resistant <i>E. coli</i> Isolate
by: Sabine Schuster, et al.
Published: (2021-04-01)

The Contribution of Efflux Pumps in <i>Mycobacterium abscessus</i> Complex Resistance to Clarithromycin
by: Júlia S. Vianna, et al.
Published: (2019-09-01)

Role of Efflux Pumps on Antimicrobial Resistance in <i>Pseudomonas aeruginosa</i>
by: Andre Bittencourt Lorusso, et al.
Published: (2022-12-01)

Chalcones Isolated from <i>Arrabidaea brachypoda</i> Flowers as Inhibitors of NorA and MepA Multidrug Efflux Pumps of <i>Staphylococcus aureus</i>
by: Luís Mário Rezende-Júnior, et al.
Published: (2020-06-01)

The Contribution of Efflux Systems to Levofloxacin Resistance in <i>Stenotrophomonas maltophilia</i> Clinical Strains Isolated in Warsaw, Poland
by: Olga M. Zając, et al.
Published: (2022-07-01)

Comparative reassessment of AcrB efflux inhibitors reveals differential impact of specific pump mutations on the activity of potent compounds
by: Sabine Schuster, et al.
Published: (2024-02-01)

Role of PatAB Transporter in Efflux of Levofloxacin in <i>Streptococcus pneumoniae</i>
by: Mónica Amblar, et al.
Published: (2022-12-01)

Efflux pumps as potential targets for biofilm inhibition
by: Jingyi Ren, et al.
Published: (2024-02-01)

A Substrate-Activated Efflux Pump, DesABC, Confers Zeamine Resistance to <named-content content-type="genus-species">Dickeya zeae</named-content>
by: Zhibin Liang, et al.
Published: (2019-06-01)

Deep analysis and optimization of CARD antibiotic resistance gene discovery models
by: Haobin Yao, et al.
Published: (2019-12-01)

Multidrug Efflux Pumps in Bacteria and Efflux Pump Inhibitors
by: Sreekantan Abhirami P., et al.
Published: (2022-10-01)

New Multidrug Efflux Systems in a Microcystin-Degrading Bacterium <em>Blastomonas fulva</em> and Its Genomic Feature
by: Long Jin, et al.
Published: (2022-09-01)

Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?
by: Renata Claro Ribeiro do Amaral, et al.
Published: (2020-11-01)

Phenylpiperazine 5,5-Dimethylhydantoin Derivatives as First Synthetic Inhibitors of Msr(A) Efflux Pump in <i>Staphylococcus epidermidis</i>
by: Karolina Witek, et al.
Published: (2020-08-01)

MexAB-OprM Efflux Pump Interaction with the Peptidoglycan of <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>
by: Miao Ma, et al.
Published: (2021-05-01)

Identification of a Novel Polyamine Scaffold With Potent Efflux Pump Inhibition Activity Toward Multi-Drug Resistant Bacterial Pathogens
by: Renee M. Fleeman, et al.
Published: (2018-06-01)

Multidrug Efflux Systems in Microaerobic and Anaerobic Bacteria
by: Zeling Xu, et al.
Published: (2015-08-01)

Interplay Between the Phenotype and Genotype, and Efflux Pumps in Drug-Resistant Strains of Riemerella anatipestifer
by: Qiwei Chen, et al.
Published: (2018-10-01)

Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes
by: Yuru Guo, et al.
Published: (2022-01-01)

Efflux Pump-Binding 4(3-Aminocyclobutyl)Pyrimidin-2-Amines Are Colloidal Aggregators
by: Tania Szal, et al.
Published: (2023-06-01)

Two putative MmpL homologs contribute to antimicrobial resistance and nephropathy of enterohemorrhagic E. coli O157:H7
by: Salma H. Hussein, et al.
Published: (2019-04-01)